Who Makes Jardiance (empagliflozin)?
Jardiance is manufactured by Boehringer Ingelheim, a pharmaceutical company based in Germany, in collaboration with US-based pharmaceutical company Eli Lilly. Jardiance is the brand name for the medication empagliflozin.
Jardiance Manufacturer Overview
| Trade Name | Jardiance |
| Manufacturer | Boehringer Ingelheim and Eli Lilly |
| Active Ingredient | Empagliflozin |
| Formula | C23H27ClO7 |
| FDA-Approval Date | August 1, 2014 |
| FDA-Approved Uses | Type 2 diabetes Heart failure with reduced ejection fraction (HFrEF) Chronic kidney disease (CKD) |
| Website | https://patient.boehringer-ingelheim.com/us/products/jardiance/ |
What Does Jardiance Treat?
Jardiance is primarily used to treat type 2 diabetes by helping to control blood sugar levels. It works by blocking the reabsorption of glucose by the kidneys, leading to its excretion in the urine.
Additionally, Jardiance has been approved for other uses, including:
- Reducing the risk of cardiovascular death and hospitalization for heart failure in adults.
- Slowing the progression of chronic kidney disease in adults with a high risk of further decline.
- Reducing the risk of cardiovascular death in adults with type 2 diabetes who also have established cardiovascular disease.
It is important to note that Jardiance is a prescription medication and should only be taken under the supervision of a healthcare professional. They can determine if Jardiance is the right treatment for your specific condition and address any potential risks or side effects.
Explore More Medication Manufacturers
Now that you know more about who makes Jardiance, the manufacturer details, and what medical conditions it treats, you may want to compare Jardiance to other medication manufacturers.
Browse the medication maker guides to research popular brands and find information on a specific company.
Who’s Query is an online encyclopedia of product owners and manufacturer information that educates users about who makes popular brands.
